Abstract (J Korean Assoc Oral Maxillofac Surg 2015;41:165-167) It has recently been reported that long-standing post-traumatic open bite can be successfully corrected with botulinum toxin type A (BTX-A) injection into the anterior belly of the digastric muscle (ABDM). The report documented an individual with bilaterally symmetrical and otherwise unremarkable anterior digastric musculature. However, the existence of variant anterior digastric musculature is common and may complicate the management of anterior open bite with BTX-A injection. Screening for variant ABDM can be accomplished via ultrasound, computed tomography, and magnetic resonance imaging. Screening for variant ABDM should be performed prior to BTX-A injection in order to account for musculature that may exert undesired forces, such as inferolateral deviation, on the anterior mandible in patients with anterior open bite.
cal; however, ABDM muscular variants have been reported to occur in as much as 69.9% of the population 3 . Diverse anatomical variations of the ABDM have included duplications, triplications, and quadrifications, in addition to exotic fractal and weave patterns of musculature [4] [5] [6] [7] [8] . Also, ABDM has been reported to cross the midline and insert contralaterally 5 . Therefore, the existence of variant ABDM should be taken into consideration when attempting to reduce fractures of the mandible. An example of a variant ABDM that may complicate BTX-A injection is shown in Fig. 1 . B.
II. Technical Note
Screening for anatomical variation of anterior digastric musculature with ultrasound (US), computed tomography (CT), and/or magnetic resonance imaging (MRI) should be performed in order to adequately plan injection of BTX-A into anterior digastric musculature. Upon imaging with US, skin can be marked directly over the digastric musculature in order to identify injection sites as variant musculature is encountered. With CT and MRI, bony references, such as the mandible and hyoid, can be used to calibrate measurements corresponding to the location of the musculature, which can subsequently be used to mark injection sites on the submental skin.
I. Introduction
Recently, Seok et al. ; therefore, by paralyzing the musculature, Seok et al. 1 were able to mitigate the forces displacing the anterior mandible. Seok et al. 1 reported, via line drawing ( Fig. 1. A), that the BTX-A injections were placed in bilaterally symmetrical anterior digastric musculature that was unremarkable with regard to anatomical variation. ABDM is typically considered to be bilaterally symmetri-BTX-A injection into the anterior digastric musculature in order to account for muscle variations that may result in undesired forces on the anterior mandible in patients with anterior open bite and to prevent undesired adverse effects of BTX-A injection.
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No potential conflict of interest relevant to this article was reported. ; however, the majority of adverse effects due to botulinum toxin injections include bruising, edema, pain at the injection site, and flulike symptoms [9] [10] [11] . The more serious side effects of injection typically result from improper needle placement due to a lack of understanding of the underlying anatomy and physiology, subsequently allowing the neurotoxin to either diffuse or be inadvertently injected into adjacent musculature [9] [10] [11] . Screening for ABDM can be accomplished via US, CT, and MRI [12] [13] [14] [15] . There are obvious differences among these imaging techniques with regard to cost, time, and invasiveness; however, to the author's knowledge, no reports have specifically compared these techniques with regard to proper identification or characterization of anterior digastric musculature.
III. Discussion
Screening for variant ABDM should be performed prior to 
